HK1138290A1 - Method of purification of hydrophobic proteins - Google Patents

Method of purification of hydrophobic proteins

Info

Publication number
HK1138290A1
HK1138290A1 HK10103641.5A HK10103641A HK1138290A1 HK 1138290 A1 HK1138290 A1 HK 1138290A1 HK 10103641 A HK10103641 A HK 10103641A HK 1138290 A1 HK1138290 A1 HK 1138290A1
Authority
HK
Hong Kong
Prior art keywords
purification
hydrophobic proteins
detergent
proteins
hydroxyapatite
Prior art date
Application number
HK10103641.5A
Other languages
English (en)
Inventor
Christa Tauer
Artur Mitterer
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of HK1138290A1 publication Critical patent/HK1138290A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK10103641.5A 2007-02-22 2010-04-14 Method of purification of hydrophobic proteins HK1138290A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90280307P 2007-02-22 2007-02-22
PCT/EP2008/001284 WO2008101667A1 (en) 2007-02-22 2008-02-19 Method of purification of hydrophobic proteins

Publications (1)

Publication Number Publication Date
HK1138290A1 true HK1138290A1 (en) 2010-08-20

Family

ID=39346160

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10103641.5A HK1138290A1 (en) 2007-02-22 2010-04-14 Method of purification of hydrophobic proteins

Country Status (10)

Country Link
US (1) US8293876B2 (ja)
EP (1) EP2129684B1 (ja)
JP (1) JP5443175B2 (ja)
CN (1) CN101616930B (ja)
AT (1) ATE496935T1 (ja)
AU (1) AU2008217189B2 (ja)
CA (1) CA2677023C (ja)
DE (1) DE602008004747D1 (ja)
HK (1) HK1138290A1 (ja)
WO (1) WO2008101667A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6227407B2 (ja) 2010-05-14 2017-11-08 バクスアルタ インコーポレイテッド Ｏｓｐａキメラおよびそのワクチンでの使用法
EP2625966A1 (en) 2012-02-13 2013-08-14 Bionanoplus, S.L. Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
EP2841098A4 (en) 2012-04-23 2016-03-02 Allertein Therapeutics Llc NANOPARTICLES FOR THE TREATMENT OF ALLERGIES
CA2879689A1 (en) 2012-07-27 2014-01-30 Baxter International Inc. Compositions comprising chimeric ospa molecules and methods of use thereof
EP2961763A4 (en) * 2013-02-28 2016-10-12 Agency Science Tech & Res CHROMATOGRAPHIC CLEANING OF ANTIBODIES FROM CELL CULTURES WITH CHROMATIN DEFICIENCY
CA2907915C (en) * 2013-04-03 2023-03-07 Allertein Therapeutics, Llc Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
JP6147340B2 (ja) * 2013-05-29 2017-06-14 Jsr株式会社 洗浄用組成物、タンパク質精製方法、及びタンパク質
SG11201603028SA (en) 2013-10-18 2016-05-30 Universität Für Bodenkultur Wien Purification of proteins
CN104710527B (zh) * 2015-02-28 2018-08-24 苏州金盟生物技术有限公司 一种生物制品的内毒素去除方法
JP2020099909A (ja) * 2020-03-17 2020-07-02 ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 処理方法、生産方法およびハイドロキシアパタイト充填剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861A (en) * 1848-10-17 Locking umbrella and parasol
GB8807860D0 (en) 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US7094391B1 (en) * 1988-10-24 2006-08-22 The University Of Texas System Compositions and methods for administering Borrelia burgdorferi antigens
US5543399A (en) * 1989-08-22 1996-08-06 Hsc Research & Development Limited Partnership Cystic fibrosis transmembrane conductance regulator (CFTR) protein
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
JP3158878B2 (ja) * 1994-07-28 2001-04-23 松下電器産業株式会社 光学式エンコーダ
US5846946A (en) * 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
US5861295A (en) * 1997-01-02 1999-01-19 Life Technologies, Inc. Nucleic acid-free thermostable enzymes and methods of production thereof
US6152944A (en) * 1997-03-05 2000-11-28 Scimed Life Systems, Inc. Catheter with removable balloon protector and stent delivery system with removable stent protector
GB9811219D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel process
ES2262333T3 (es) * 1998-08-14 2006-11-16 MERCK & CO., INC. Procedimiento para purificar particulas similares a virus de papilomavirus humano.
GB0100513D0 (en) * 2001-01-09 2001-02-21 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
JP5443175B2 (ja) 2014-03-19
US20080249014A1 (en) 2008-10-09
DE602008004747D1 (de) 2011-03-10
CN101616930A (zh) 2009-12-30
EP2129684A1 (en) 2009-12-09
CN101616930B (zh) 2013-05-08
CA2677023A1 (en) 2008-08-28
ATE496935T1 (de) 2011-02-15
AU2008217189B2 (en) 2013-06-13
JP2010518836A (ja) 2010-06-03
US8293876B2 (en) 2012-10-23
AU2008217189A1 (en) 2008-08-28
CA2677023C (en) 2016-08-30
WO2008101667A1 (en) 2008-08-28
EP2129684B1 (en) 2011-01-26

Similar Documents

Publication Publication Date Title
HK1138290A1 (en) Method of purification of hydrophobic proteins
ZA200900836B (en) Process for the purification of FC-fusion proteins
DE602007009295D1 (de) Verfahren zur vorbereitenden rna-reinigung mittels hplc
BRPI0917993A2 (pt) composições de célula-tronco mesenquimal purificada e métodos de purificação de composições de célula-tronco mesenquimal purificda.
HK1131400A1 (en) Process for the purification of fc-containing proteins
MX2007007682A (es) Proceso para depurar polioles polimericos.
DK1789445T3 (da) Fremgangsmåde til fjernelse af fibronektin fra plasmafraktioner
CA2705357C (en) Formulations for taci-immunoglobulin fusion proteins
HK1203571A1 (en) Method for the purification of radium from different sources
NO20080131L (no) Fremgangsmate for rensing av IL-18 bindende protein
CY1114562T1 (el) Υψηλης καθαροτητας μεγαλης κλιμακας παρασκευη στανσοπορφινης
PL1960521T3 (pl) Sposób i zestaw do rozdzielania, oczyszczania i odzyskiwania długo- i krótkołańcuchowych kwasów nukleinowych
ZA200900837B (en) Process for the purification of FC-containing proteins
DK1842908T3 (da) Fremgangsmåde til fremstilling af oprenset lipase
IL185032A0 (en) Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
MX2013013224A (es) Procedimiento de purificacion de proteinas de bajo ph.
WO2012066569A8 (en) A novel process for the purification of tissue plasminogen activator
IL210346A0 (en) Separation/purification of desflurane from hydrogen fluoride
HUP0501144A2 (en) Process for separation of optical isomers by liquid chromatography
IL199752A0 (en) Purification of taci-fc
EA201270403A1 (ru) Способ и система для очистки полипептидов
SG155231A1 (en) Process for synthesis of dialkoxyorganoboranes
WO2008097828A3 (en) Method for isolating mesenchymal stromal cells
MX2012000087A (es) Metodo cromatografico basado en gradiente no lineal preparativo y productos purificados del mismo.
WO2012082723A3 (en) Purification of immunogens using a non-polysaccharide matrix